Abstract

.Although the high case fatality rate (CFR) associated with Ebola virus disease (EVD) is well documented, there are limited data on the actual modes of death. We conducted a retrospective, observational cohort study among patients with laboratory-confirmed EVD. The patients were all seen at the Eternal Love Winning Africa Ebola Treatment Unit in Monrovia, Liberia, from June to August 2014. Our primary objective was to describe the modes of death of our patients and to determine predictors of mortality. Data were available for 53 patients with laboratory-confirmed EVD, with a median age of 35 years. The most frequent presenting symptoms were weakness (91%), fever (81%), and diarrhea (78%). Visible hemorrhage was noted in 25% of the cases. The CFR was 79%. Odds of death were higher in patients with diarrhea (odds ratio = 26.1, P < 0.01). All patients with hemorrhagic signs died (P < 0.01). Among the 18 fatal cases for which clinical information was available, three distinct modes of death were observed: sudden death after a moderate disease process (44%), profuse hemorrhage (33%), and encephalopathy (22%). We found that these modes of death varied by age (P = 0.04), maximum temperature (P = 0.43), heart rate on admission (P = 0.04), time to death from symptom onset (P = 0.13), and duration of hospitalization (P = 0.04). Although further study is required, our findings provide a foundation for developing treatment strategies that factor in patients with specific disease phenotypes (which often require the use of aggressive hydration). These findings provide insights into underlying pathogenic mechanisms resulting in severe EVD and suggest direction for future research and development of effective treatment options.

Highlights

  • The 2013–2016 West Africa Ebola virus disease (EVD) outbreak was unprecedented, given its duration, geographic scope, and high caseload of more than 28,600 reported cases and 11,300 deaths.[1]

  • The Liberian MOH had set up an Ebola Treatment Units (ETUs) at John F Kennedy Hospital in Monrovia, but all the patients were transferred to ELWA-2 on its opening

  • Of the 69 patients admitted to the ELWA-1 and ELWA-2 ETUs from June to August 2014, 53 (77%) were confirmed EVD cases

Read more

Summary

Introduction

The 2013–2016 West Africa Ebola virus disease (EVD) outbreak was unprecedented, given its duration, geographic scope, and high caseload of more than 28,600 reported cases and 11,300 deaths.[1] In Monrovia, Liberia, faith-based organizations (Samaritan’s Purse and SIM) developed and operated the Eternal Love Winning Africa (ELWA-1 and 2) Ebola Treatment Units (ETUs) from June to August 2014, with the support of Medecins Sans Frontieres-Belgium (MSF-B). Fear prompted the surrounding community to arm themselves with machetes and protest in front of ELWA-2, demanding its closure in late July. This resulted in delays in developing the ELWA-3 ETU, which was intended to provide additional bed capacity. ELWA-2 was the only functioning ETU in Monrovia at the end of July 2014

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call